- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: osteolytic lesions of multiple myeloma
Total 429264 results
-
CelgeneCompletedMultiple MyelomaRussian Federation
-
University of AthensCompleted
-
National Cancer Institute (NCI)CompletedHIV Infection | Clear Cell Renal Cell Carcinoma | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell... and other conditionsUnited States
-
Institut Paoli-CalmettesCompletedMultiple Myeloma and Plasma Cell NeoplasmFrance
-
Instituto do Cancer do Estado de São PauloRecruitingMultiple MyelomaBrazil
-
Cliniques universitaires Saint-Luc- Université...Recruiting
-
Centre Georges Francois LeclercRecruitingMultiple MyelomaFrance
-
Dana-Farber Cancer InstituteThe Leukemia and Lymphoma SocietyRecruitingMyelodysplastic-Myeloproliferative Diseases | Waldenstrom Macroglobulinemia | Smoldering Multiple Myeloma | Chronic Lymphocytic Leukemia (CLL) | Hematological Malignancies | Monoclonal Gammopathy of Undetermined Significance (MGUS) | B-cell Malignancy, Low-grade | Myelodysplastic Syndrome With Low-grade... and other conditionsUnited States
-
AmgenDaiichi Sankyo, Inc.CompletedCancer | Multiple Myeloma | Bone Metastases | Hematologic Malignancies | Oncology | Multiple Myeloma Bone LesionsUnited States, Germany, Italy, Spain, Canada, France, Czechia, Hungary, Korea, Republic of, Russian Federation, United Kingdom, Taiwan, Australia, Hong Kong, New Zealand, Austria, Slovakia, Portugal, Greece, Bulgaria, Poland, Ukraine and more
-
AmgenCompleted
-
Yale UniversityCompleted
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
Centre Hospitalier Universitaire, AmiensCompleted
-
Medtronic Spine LLCCompletedMultiple Myeloma | Bone Neoplasms | Osteoporosis | OsteopeniaUnited States
-
Herlev HospitalCompleted
-
NYU Langone HealthCompletedMultiple Myeloma | Osteoporosis | Disease of the MarrowUnited States
-
NovartisWithdrawn
-
Assistance Publique - Hôpitaux de ParisTerminatedMultiple Myeloma | Vertebral Fracture | Osteolytic MetastasesFrance
-
NovartisCompletedBreast Cancer | Multiple Myeloma | Prostate CancerUnited States
-
PhotocureCompletedCervical DysplasiaGermany, Norway
-
Glaxo WellcomeCompletedHIV Infections | Herpes Simplex
-
Ontario Clinical Oncology Group (OCOG)PfizerNot yet recruitingRefractory Multiple MyelomaCanada
-
Nantes University HospitalNot yet recruiting
-
Kite, A Gilead CompanyArcellx, Inc.Not yet recruiting
-
Jules Bordet InstituteRayzeBio, Inc.Not yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory | Multiple Myeloma ProgressionBelgium
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingMultiple Myeloma | Newly Diagnosed | MRD | High Risk
-
University Hospital, AngersNot yet recruiting
-
Shanghai Changzheng HospitalCARsgen Therapeutics Co., Ltd.Not yet recruitingHigh-risk Newly Diagnosed Multiple Myeloma (HRNDMM)
-
CelgeneBristol-Myers SquibbRecruitingMultiple MyelomaAustria, United States, Spain, Australia, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom, Poland
-
Peking University First HospitalRecruiting
-
IRCCS Policlinico S. MatteoRecruitingAL Amyloidosis | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaItaly
-
Cullinan Therapeutics Inc.Not yet recruiting
-
Changzhou No.2 People's HospitalNot yet recruiting
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.Not yet recruitingRelapsed or Refractory Multiple MyelomaChina
-
Dickran Kazandjian, MDRegeneron PharmaceuticalsNot yet recruiting
-
Peking University People's HospitalNot yet recruitingRelapsed/Refractory Multiple MyelomaChina
-
Tufts Medical CenterNational Cancer Institute (NCI)Not yet recruitingSmoldering Multiple MyelomaUnited States
-
Wuhan Union Hospital, ChinaNot yet recruitingMultiple Myeloma
-
Bristol-Myers SquibbRecruitingMultiple Myeloma | Non-Hodgkin Lymphoma | Chronic Lymphocytic LeukaemiaBelgium
-
SanofiNot yet recruiting
-
Nantes University HospitalJanssen PharmaceuticaNot yet recruiting
-
Adriana RossiNot yet recruitingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingLymphoma, B-Cell | Multiple Myeloma | Acute Lymphoblastic Leukemia | Hematologic Malignancy | Car T- CellFrance
-
Thomas Martin, MDBristol-Myers Squibb; Janssen Research & Development, LLCNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingMultiple Myeloma | Newly Diagnosed Multiple Myeloma | Autologous Stem Cell TransplantationUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); The Foundation for Barnes-Jewish HospitalRecruitingMultiple Myeloma | Rectal Cancer | Cholangiocarcinoma | Colon CancerUnited States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Not yet recruiting
-
Emory UniversityNational Cancer Institute (NCI); National Center for Complementary and Integrative...RecruitingLymphoma | Multiple MyelomaUnited States
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Jinling Hospital, ChinaRecruitingNewly Diagnosed Multiple MyelomaChina